<DOC>
	<DOCNO>NCT00603538</DOCNO>
	<brief_summary>Investigate safety , tolerability pharmacokinetics CP-751,871 give combination carboplatin paclitaxel patient advance non-small cell lung cancer</brief_summary>
	<brief_title>Study CP-751,871 Combination With Carboplatin Paclitaxel Advanced Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>Diagnosis advance nonsmall cell lung cancer Eastern Cooperative Oncology Group ( ECOG ) performance status 0 1 Any prior treatment nonsmall cell lung cancer Brain metastases With diabetes</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>CP-751,871 , Non-small cell lung cancer , Phase 1</keyword>
</DOC>